Oriental Carbon and Chemicals (OCCL) Q4 17/18 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 17/18 earnings summary
2 Nov, 2026Executive summary
FY18 standalone net sales rose to Rs. 33,202.51 lakh from Rs. 31,057.99 lakh; PAT reached Rs. 5,675.01 lakh, while margins remained stable.
Insoluble Sulphur sales grew ~10% after the third Mundra line began operating; Phase II capacity expansion was progressing on schedule and within budget.
Consolidated revenue was Rs. 37,376.09 lakh and PAT was Rs. 5,689.78 lakh; the subsidiary returned to profit after a prior-year loss.
Financial highlights
Standalone revenue from operations was Rs. 33,202.51 lakh vs Rs. 31,057.99 lakh; total revenue was Rs. 33,757.04 lakh vs Rs. 31,736.10 lakh.
Standalone PBT increased to Rs. 7,963.31 lakh from Rs. 7,471.71 lakh; PAT rose to Rs. 5,675.01 lakh from Rs. 5,417.37 lakh.
Consolidated revenue from operations was Rs. 37,376.09 lakh vs Rs. 34,910.41 lakh; consolidated PAT was Rs. 5,689.78 lakh vs Rs. 4,829.78 lakh.
Standalone operating cash flow was Rs. 8,659.26 lakh vs Rs. 7,713.49 lakh; year-end cash and cash equivalents were Rs. 962.21 lakh.
Outlook and guidance
Phase II Insoluble Sulphur expansion at Mundra was expected to be commissioned on schedule; new capacity was targeted to operate at optimum levels by the end of FY19.
China and US market entry had received a positive response; these geographies were identified as growth drivers for new capacity.
Domestic Insoluble Sulphur demand was expected to grow at double-digit rates; global demand growth was estimated at 3–4% annually.
Sulphuric Acid demand was expected to benefit from a normal monsoon and stronger fertilizer production.
Latest events from Oriental Carbon and Chemicals
- Profitable growth and a ₹216 crore expansion plan advance the next capacity phase.OCCL
Q4 18/19 - COVID-19 hit FY20 results; FY21 outlook signaled lower sales and delayed expansion.OCCL
Q4 19/20 - Higher margins lifted PAT despite weaker sales; Mundra expansion was due in April 2017.OCCL
Q4 15/16 - Mundra expansion and Insoluble Sulphur growth drive the FY2016-17 outlook.OCCL
Q4 16/17 - FY15 profit advanced as Insoluble Sulphur demand and capacity utilization strengthened.OCCL
Q4 14/15 - FY14 growth was led by Insoluble Sulphur, with expansion prospects shadowed by SEZ uncertainty.OCCL
Q4 13/14 - Sales rose, but lower tyre demand and higher costs cut earnings as Mundra Phase II ramped up.OCCL
Q4 12/13 - FY11 profit rose as capacity expansion targeted strong Insoluble Sulphur demand.OCCL
Q4 10/11 - Revenue grew 37%, while Mundra expansion lifted Insoluble Sulphur capacity amid higher costs and market risks.OCCL
Q4 11/12